Exact FDA event identifier

Event 71219

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: March 02, 2015
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: American Health Packaging

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Lamivudine and Zidovudine Tablets USP 150mg/300mg 30 Unit Dose Blisters, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton of 30: NDC 68084-0416-21, Individual dose: NDC 68084-0416-11

D-1140-2015

Recall number: D-1140-2015
Initiated: March 02, 2015
Classification: Class II
Status: Terminated
Recalling firm: American Health Packaging
Quantity: 925 cartons (30 tablets in each carton)

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Failed dissolution specifications

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed dissolution specifications

Code information

Lot #140849

Distribution pattern

Nationwide